ArticleBMC cancer2026

Construction of a novel signature based on CRISPR-Cas9 screening for prognostic prediction in breast cancer.

Wen-Tao Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.